NEW DELHI: Bharat Biotech on Wednesday signed a licensing agreement with the Washington University School of Medicine in St Louis, USA, for a new intranasal single dose “chimpanzee adenovirus” vaccine for Covid-19. As Covid cases continue to show an increase around the world, several nations are working on vaccines that …
Read More »Bharat Biotech signs a license agreement with the University of Washington School of Medicine for the intranasal Covid vaccine
Bharat Biotech, a leading vaccine and biotherapeutics manufacturer, has entered into a licensing agreement with Washington University School of Medicine in St. Louis, Missouri, USA, for a single-dose intranasal vaccine for coronavirus disease. (Covid-19). Bharat Biotech owns the rights to distribute the vaccine in all markets except the United States, …
Read More »